Understand the source comparison
TB-4 Anti-Fibrotic Complete Guide 2026: Comparison
Research teams evaluating TB-4 against alternative anti-fibrotic agents must weigh mechanism specificity, tissue selectivity, and administration complexity. The table below compares TB-4 to three common fibrosis-modulating compounds used in experimental protoc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research teams evaluating TB-4 against alternative anti-fibrotic agents must weigh mechanism specificity, tissue selectivity, and administration complexity. The table below compares TB-4 to three common fibrosis-modulating compounds used in experimental protocols.
- TB-4
- MMP-2/9 upregulation + TGF-β1 inhibition
- Cardiac, skeletal, dermal, hepatic
- Subcutaneous injection
- 48–72 hours post-dose
- Gold standard for multi-tissue fibrosis; requires reconstitution expertise
- Pirfenidone
- TGF-β downregulation + collagen synthesis inhibition
- Pulmonary (highly selective)
- Oral capsule
- 7–14 days
- FDA-approved for IPF; poor efficacy outside lung tissue
- Losartan (ARB)
- Angiotensin II receptor blockade → reduced TGF-β
- Renal, cardiac (moderate selectivity)
- Oral tablet
- 5–10 days
- Indirect anti-fibrotic via blood pressure modulation; requires chronic dosing
- N-Acetylcysteine (NAC)
- Antioxidant-mediated reduction in ROS-driven fibrosis
- Hepatic, pulmonary (broad but weak)
- Oral or IV
- Variable (14+ days)
- Weak standalone agent; best as adjunct to primary anti-fibrotic
- TB-4's advantage lies in its dual-pathway action. It both degrades existing collagen and blocks new fibrosis formation. While remaining effective across multiple tissue types. Pirfenidone is highly specific to pulmonary fibrosis and offers minimal benefit in cardiac or hepatic models. Losartan's anti-fibrotic effect is secondary to its hemodynamic action, making it less suitable for isolated fibrosis studies where blood pressure manipulation is a confounding variable.